Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Database
Language
Document Type
Year range
1.
Clin Lab Med ; 41(2): 185-202, 2021 06.
Article in English | MEDLINE | ID: covidwho-1232935

ABSTRACT

Various analytical methods can be applied to concentrate, separate, and examine trace volatile organic metabolites in the breath, with the potential for noninvasive, rapid, real-time identification of various disease processes, including an array of microbial infections. Although biomarker discovery and validation in microbial infections can be technically challenging, it is an approach that has shown great promise, especially for infections that are particularly difficult to identify with standard culture and molecular amplification-based approaches. This article discusses the current state of breath analysis for the diagnosis of infectious diseases.


Subject(s)
Communicable Diseases , Volatile Organic Compounds , Breath Tests , Communicable Diseases/diagnosis , Humans
2.
Transpl Infect Dis ; 23(4): e13645, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1238475

ABSTRACT

As some of those who were lucky enough to have been mentored by Dr Francisco Marty in transplant infectious diseases, we stand with the larger medical community in mourning his untimely death and in commemorating him as a uniquely exceptional and talented physician, investigator, teacher, mentor, friend, artist, and human being.


Subject(s)
Physicians , Humans , Male
3.
Clin Infect Dis ; 71(10): 2744-2751, 2020 12 17.
Article in English | MEDLINE | ID: covidwho-1066273

ABSTRACT

The clinical signs and symptoms of acute respiratory tract infections (RTIs) are not pathogen specific. Highly sensitive and specific nucleic acid amplification tests have become the diagnostic reference standard for viruses, and translation of bacterial assays from basic research to routine clinical practice represents an exciting advance in respiratory medicine. Most recently, molecular diagnostics have played an essential role in the global health response to the novel coronavirus pandemic. How best to use newer molecular tests for RTI in combination with clinical judgment and traditional methods can be bewildering given the plethora of available assays and rapidly evolving technologies. Here, we summarize the current state of the art with respect to the diagnosis of viral and bacterial RTIs, provide a practical framework for diagnostic decision making using selected patient-centered vignettes, and make recommendations for future studies to advance the field.


Subject(s)
COVID-19 , Respiratory Tract Infections , Viruses , Humans , Molecular Diagnostic Techniques , Respiratory Tract Infections/diagnosis , SARS-CoV-2 , Viruses/genetics
SELECTION OF CITATIONS
SEARCH DETAIL